Yan Zhong

Shijiazhuang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Esaxerenone attenuates high salt-induced hypertension and renal damage via CD8+T cell- associated NCC activation in aldosterone treated rats.

Esaxerenone attenuates high salt-induced hypertension and renal damage via CD8+T cell- associated NCC activation in aldosterone treated rats.

Journal: The Journal of steroid biochemistry and molecular biology

Published: September 04, 2025

Corrigendum to "Empagliflozin attenuating renal interstitial fibrosis in diabetic kidney disease by inhibiting lymphangiogenesis and lymphatic endothelial-to-mesenchymal transition via the VEGF-C/VEGFR3 pathway" [Biomed. Pharmacother. 180 (2024) 117589].

Corrigendum to "Empagliflozin attenuating renal interstitial fibrosis in diabetic kidney disease by inhibiting lymphangiogenesis and lymphatic endothelial-to-mesenchymal transition via the VEGF-C/VEGFR3 pathway" [Biomed. Pharmacother. 180 (2024) 117589].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 15, 2025

The critical role of the Hippo signaling pathway in renal fibrosis.

The critical role of the Hippo signaling pathway in renal fibrosis.

Journal: Cellular signalling

Published: November 21, 2024

Empagliflozin attenuating renal interstitial fibrosis in diabetic kidney disease by inhibiting lymphangiogenesis and lymphatic endothelial-to-mesenchymal transition via the VEGF-C/VEGFR3 pathway.

Empagliflozin attenuating renal interstitial fibrosis in diabetic kidney disease by inhibiting lymphangiogenesis and lymphatic endothelial-to-mesenchymal transition via the VEGF-C/VEGFR3 pathway.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 13, 2024

SPDEF ameliorates UUO-induced renal fibrosis by transcriptional activation of NR4A1.

SPDEF ameliorates UUO-induced renal fibrosis by transcriptional activation of NR4A1.

Journal: Molecular medicine (Cambridge, Mass.)

Published: May 24, 2024

The roles of orphan nuclear receptor 4 group A1 and A2 in fibrosis.

The roles of orphan nuclear receptor 4 group A1 and A2 in fibrosis.

Journal: International immunopharmacology

Published: May 16, 2024

Nuclear receptor 4A1 ameliorates UUO-induced renal fibrosis by inhibiting the PI3K/AKT pathway.

Nuclear receptor 4A1 ameliorates UUO-induced renal fibrosis by inhibiting the PI3K/AKT pathway.

Journal: Scientific reports

Published: January 17, 2024

Nuclear receptor 4A1 ameliorates renal fibrosis by inhibiting vascular endothelial growth factor A induced angiogenesis in UUO rats.

Nuclear receptor 4A1 ameliorates renal fibrosis by inhibiting vascular endothelial growth factor A induced angiogenesis in UUO rats.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: December 20, 2023

The role of PI3K/Akt signaling pathway in chronic kidney disease.

The role of PI3K/Akt signaling pathway in chronic kidney disease.

Journal: International urology and nephrology

Published: October 13, 2023

Losartan ameliorates renal fibrosis by inhibiting tumor necrosis factor signal pathway.

Losartan ameliorates renal fibrosis by inhibiting tumor necrosis factor signal pathway.

Journal: Nefrologia

Published: May 18, 2023

The nuclear receptor subfamily 4 group A1 in human disease.

The nuclear receptor subfamily 4 group A1 in human disease.

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: March 02, 2023

Tumor supernatant derived from hepatocellular carcinoma cells treated with vincristine sulfate have therapeutic activity.

Tumor supernatant derived from hepatocellular carcinoma cells treated with vincristine sulfate have therapeutic activity.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: April 23, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026